Literature DB >> 3035099

Depletion of myo-inositol and amino acids in galactosemic neuropathy.

C Nishimura, M F Lou, J H Kinoshita.   

Abstract

A depletion of not only myo-inositol (MI) but also taurine and other amino acids was observed in the sciatic nerve of a galactosemic rat. Treatment of the galactosemic rats with sorbinil, an aldose reductase (AR) inhibitor, was found to block galactitol formation and protect against the loss of MI, taurine, and other amino acids. Incubation studies of sciatic nerve have revealed that [3H]MI and [3H]taurine were actively taken up and concentrated. Incubation of the nerve in a high-galactose medium showed a decrease in the accumulation of [3H]MI and [3H]taurine whereas the galactitol level increased. Time-course studies have shown that the galactitol level reached a plateau before a substantial decrease in the accumulation of [3H]MI and [3H]taurine occurred. The addition of AR inhibitors in the galactose medium significantly protected against the loss in the capacity of the nerve to accumulate [3H]MI and [3H]taurine. Hypertonicity of the galactose medium also seemed to have a protective effect similar to that of AR inhibitors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035099     DOI: 10.1111/j.1471-4159.1987.tb03428.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene.

Authors:  A E Heesom; A Millward; A G Demaine
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

2.  Characterization of the osmotic response element of the human aldose reductase gene promoter.

Authors:  B Ruepp; K M Bohren; K H Gabbay
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Feedback inhibition of aldose reductase gene expression in rat renal medulla. Galactitol accumulation reduces enzyme mRNA levels and depletes cellular inositol content.

Authors:  C Bondy; B D Cowley; S L Lightman; P F Kador
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients.

Authors:  C Nishimura; T Saito; T Ito; Y Omori; T Tanimoto
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 5.  The role of polyols in the pathophysiology of hypergalactosemia.

Authors:  G T Berry
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 6.  Inositols Depletion and Resistance: Principal Mechanisms and Therapeutic Strategies.

Authors:  Elisa Lepore; Rosa Lauretta; Marta Bianchini; Marilda Mormando; Cherubino Di Lorenzo; Vittorio Unfer
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 7.  Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders.

Authors:  Simona Dinicola; Mirko Minini; Vittorio Unfer; Roberto Verna; Alessandra Cucina; Mariano Bizzarri
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.